Traction News and Research

RSS

Delaney’s debate claim that ‘Medicare for All’ will shutter hospitals goes overboard

At the first Democratic presidential primary debate, former Rep. John Delaney (Md.) outlined his opposition to "Medicare for All" and focused on one potential loser: hospitals.

27 Jun 2019

Poor sleep associated with high blood pressure

A bad night's sleep may result in a spike in blood pressure that night and the following day, according to new research led by the University of Arizona.

4 Jun 2019

Oklahoma’s ‘precedent-setting’ suit puts opioid drugmakers on trial

All eyes will be on Oklahoma this week when the first case in a flood of litigation against opioid drug manufacturers begins Tuesday.

28 May 2019

For civilians, finding a therapist skilled in PTSD treatments is a tough task

Lauren Walls has lived with panic attacks, nightmares and flashbacks for years. The 26-year-old San Antonio teacher sought help from a variety of mental health professionals — including spending five years and at least $20,000 with one therapist who used a Christian-faith-based approach, viewing her condition as part of a spiritual weakness that could be conquered — but her symptoms worsened. She hit a breaking point two years ago, when she contemplated suicide.

22 May 2019

Is it a feminist right to want more sex? One company thinks a pill is the answer

Studies have never defined a "normal" level of sexual desire. Despite that, there's a website and an online quiz to help you decide if you've got a problem. Called "Right to Desire," it brands libido as a feminist "right," and its home page offers the defiant, in-your-face prompt: "Yes, I want my desire back."

11 May 2019

HIV prevention pill may be cost-effective way of curbing the epidemic in India

Pre-exposure prophylaxis, a combination drug used to prevent HIV infection, has already gained significant traction in the U.S. and Europe.

10 May 2019

CBO’s report on single-payer health care holds more questions than answers

Progressive Democrats have rallied around "Medicare-for-all," a single-payer health plan popularized by Sen. Bernie Sanders (I-Vt.). Now, some of Washington's official bean counters are trying to add a new framework around what it might look like. The picture they offer highlights just how complicated that shift might be.

1 May 2019

Brain areas linked to memory and emotion aid odor navigation in humans

Species like dogs and rodents use their sense of smell to navigate toward desirable items and places and away from those they should avoid.

22 Apr 2019

Triple negative breast cancer develop resistance to chemotherapy by turning on molecular pathway

Researchers at The University of Texas MD Anderson Cancer Center have discovered that triple negative breast cancer cells can develop resistance to frontline, or neoadjuvant, chemotherapy not by acquiring permanent adaptations, but rather transiently turning on molecular pathways that protect the cells.

19 Apr 2019

Eat intuitively, not restrictively

Listening to the body's cues and acting on these cues, instead of ignoring them, may improve diet success, according to researchers.

5 Apr 2019

New technique measures frequency of sounds emitted from biological structures

Did you know that music and diagnostic imaging have something in common? Sounds have a lower or higher pitch depending on the size of the object that creates them.

25 Mar 2019

Researchers elucidate how embryonic cells and tissues respond to force

Accumulated evidence suggests that physical force plays an important role in various developmental processes of fertilized animal eggs.

8 Mar 2019

Quanterix corporation releases operating results for fourth quarter and full year 2018

Quanterix announced financial results for the three months and twelve months ended Dec. 31, 2018.

From Quanterix 7 Mar 2019

Oxford Genetics successfully negotiates six licensing deals

Mercia Technologies PLC, the national investment group focused on the identification, creation, funding and scaling of innovative technology businesses with high growth potential from the UK regions, today announces that its portfolio company, Oxford Genetics Limited, has successfully negotiated six licensing deals for its scalable gene therapy manufacturing technologies in the last twelve months.

From OXGENE 5 Mar 2019